
Samsung TV Plus Tops 100 Million Monthly Users as FAST Becomes Strategic Growth Engine
Samsung Electronics has surpassed 100 million monthly active users for Samsung TV Plus, a milestone that underscores how
Curated content that matters
Explore stories across diverse categories

Samsung Electronics has surpassed 100 million monthly active users for Samsung TV Plus, a milestone that underscores how

A South Korean court on 2/12 local time ordered K-pop giant Hybe to pay about $19 million to

South Korea’s antitrust regulator said on 2/12 local time that it will impose fines totaling about $3.0 billion

Samsung Electronics said on 2/12 that it has begun the world’s first mass shipments of its sixth-generation high-bandwidth
Photo=Motionelements K-pop group BTS will stage a free live concert on 3/21 at 8:00 p.m. local time to mark the release of its fifth full-length album, ARIRANG, with ticket reservations opening later this month. According to an announcement posted on the fan platform Weverse at 12:00 a.m. on 2/9, ticketing for the event, titled “BTS The Comeback Live | ARIRANG,”
Photo=Motionelements Samsung Electronics ranked first among global companies in the number of U.S. patents granted last year, marking its fourth consecutive year at the top, according to a report released 2/8 by patent analytics firm IFI Claims. A total of 323,272 patents were registered in the United States in 2025, the report showed. Samsung Electronics secured 7,054 patents, accounting for
The cost of preparing a traditional Lunar New Year ceremonial table in South Korea rose by more than 4% from a year earlier, underscoring how food inflation remains embedded in household budgets during one of the country’s most important holidays. In South Korea, Seollal, as the Lunar New Year is known, is a multiday family gathering centered on ancestral rites
(Photo=Hotel Shilla) The global travel-retail industry is still recalibrating after the pandemic, with airport and inflight duty-free operators facing thinner margins, volatile passenger flows and rising financing costs. As those pressures persist, companies are increasingly reassessing whether overseas investments built for a pre-2020 growth cycle still justify the capital they tie up. Against that backdrop, Hotel Shilla, a South Korean
(Photo=Celltrion) In the U.S. healthcare system, access matters more than approval. A drug can clear regulators and still fail commercially if it cannot pass through the tightly controlled formularies run by pharmacy benefit managers. This month, one South Korean pharmaceutical company crossed that threshold in one of the most closely guarded corners of the American drug market. Celltrion has secured